Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Generic enzyme 11
[{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa42/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa42/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa41/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa41/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa40/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa40/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa3f/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa3f/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa3e/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa3e/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa3d/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa3d/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa3c/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa3c/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa3b/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa3b/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa3a/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa3a/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa39/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa39/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa38/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa38/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa37/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa37/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa36/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa36/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa35/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa35/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa34/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa34/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa33/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa33/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa32/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa32/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa31/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa31/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa30/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa30/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa2f/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa2f/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa2e/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa2e/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa2d/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa2d/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa2c/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa2c/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa2b/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa2b/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa2a/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa2a/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa29/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa29/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa28/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa28/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa27/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa27/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa26/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa26/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa25/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa25/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa24/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa24/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa23/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa23/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa22/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa22/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa21/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa21/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa20/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa20/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa1f/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa1f/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa1e/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa1e/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa1d/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa1d/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa1c/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa1c/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa1b/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa1b/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa1a/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa1a/5d2ce3fdf02f730400c4fa18.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce430f02f730400c4fa19/5d2ce3fdf02f730400c4fa18.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce430f02f730400c4fa19/5d2ce3fdf02f730400c4fa18.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
receptor,ligand,target ligand,targeting ligand,targeted ligand,protein,pathway,signaling,cascade,diagram,transcription factor,generic,catalyst,enzyme,substrate,lock and key
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
